| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,232.00
Est. +10%
|
$1,117.26 | $1,238.00 |
Bullseye Hit (±1%)
|
$1,210.50
+8.3%
|
| May 26, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,119.00
Est. +5%
|
$1,065.00 | $1,238.00 |
Target Met
|
$1,210.50
+13.7%
|
| May 21, 2026 |
Roivant Sciences Ltd
ROIV
|
BUY |
$42.00
Est. +30%
|
$32.41 | $35.90 |
Pending
|
$35.13
+8.4%
|
| May 13, 2026 |
Johnson & Johnson
JNJ
|
BUY |
$265.00
Est. +18%
|
$224.26 | $263.06 |
Bullseye Hit (±1%)
|
$263.04
+17.3%
|
| Mar 05, 2026 |
AMGEN Inc.
AMGN
|
SELL |
$355.00
Est. +3%
|
$367.60 | $320.53 (Low) |
Target Met
|
$374.15
-1.8%
|
| Jan 13, 2026 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$60.00
Est. +6%
|
$56.39 | $62.89 |
Target Met
|
$58.13
+3.1%
|
| Jan 05, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,234.00
Est. +14%
|
$1,080.36 | $1,238.00 |
Bullseye Hit (±1%)
|
$1,210.50
+12.0%
|
| Dec 15, 2025 |
Roivant Sciences Ltd
ROIV
|
BUY |
$32.00
Est. +45%
|
$22.10 | $35.90 |
Target Met
|
$35.13
+59.0%
|
| Dec 11, 2025 |
XOMA Royalty Corp.
XOMA
|
BUY |
$45.00
Est. +70%
|
$26.51 | $43.00 |
Pending
|
$43.00
+62.2%
|
| Nov 19, 2025 |
Vaxcyte Inc
PCVX
|
BUY |
$77.00
Est. +55%
|
$49.53 | $64.79 |
Pending
|
$58.39
+17.9%
|
| Nov 11, 2025 |
Roivant Sciences Ltd
ROIV
|
BUY |
$29.00
Est. +37%
|
$21.17 | $35.90 |
Target Met
|
$35.13
+65.9%
|
| Jul 14, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$114.00
Est. +2%
|
$112.09 | $157.27 |
Target Met
|
$131.27
+17.1%
|
| Nov 13, 2024 |
Theravance Biopharma Inc
TBPH
|
BUY |
$10.00
Est. +31%
|
$7.66 | $18.96 |
Target Met
|
$16.93
+121.0%
|
| Nov 06, 2024 |
AnaptysBio Inc
ANAB
|
BUY |
$45.00
Est. +132%
|
$19.38 | $27.31 |
Miss
|
$63.42
+227.2%
|
| Nov 06, 2024 |
Vaxcyte Inc
PCVX
|
BUY |
$135.00
Est. +26%
|
$106.74 | $116.00 |
Miss
|
$58.39
-45.3%
|
| Oct 21, 2024 |
Roivant Sciences Ltd
ROIV
|
BUY |
$17.00
Est. +43%
|
$11.92 | $18.06 |
Target Met
|
$35.13
+194.7%
|
| Oct 03, 2024 |
AnaptysBio Inc
ANAB
|
SELL |
$35.00
Est. +1%
|
$35.22 | $8.14 (Low) |
Target Met
|
$63.42
-80.1%
|
| Sep 24, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
SELL |
$1,077.00
Est. +1%
|
$1,091.98 | $476.49 (Low) |
Target Met
|
$654.27
+40.1%
|
| Sep 03, 2024 |
Vaxcyte Inc
PCVX
|
BUY |
$153.00
Est. +37%
|
$112.04 | $121.06 |
Miss
|
$58.39
-47.9%
|
| Apr 16, 2024 |
AnaptysBio Inc
ANAB
|
BUY |
$47.00
Est. +121%
|
$21.27 | $27.54 |
Miss
|
$63.42
+198.2%
|
| Oct 12, 2023 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$66.00
Est. +17%
|
$56.25 | $54.54 |
Miss
|
$58.13
+3.3%
|
| May 25, 2022 |
HilleVax Inc
HLVX
|
BUY |
$30.00
Est. +197%
|
$10.11 | - | - |
$2.09
-79.3%
|
| May 24, 2022 |
Abbvie Inc
ABBV
|
SELL |
$140.00
Est. +5%
|
$148.03 | - | - |
$261.07
-76.4%
|
| May 23, 2022 |
Lilly(Eli) & Co
LLY
|
BUY |
$341.00
Est. +13%
|
$302.76 | - | - |
$1,210.50
+299.8%
|
| May 23, 2022 |
Pfizer Inc.
PFE
|
BUY |
$55.00
Est. +4%
|
$52.88 | - | - |
$24.32
-54.0%
|
| May 23, 2022 |
Gilead Sciences, Inc.
GILD
|
BUY |
$68.00
Est. +6%
|
$64.04 | - | - |
$131.27
+105.0%
|